Cite
HARVARD Citation
Khamis, R. et al. (2011). 9 IgG anti-malonedialdehyde-LDL antibodies are associated with low risk of cardiovascular events in a substudy of the anglo-scandinavian cardiac outcomes trial (Ascot), and are unrelated To LDL, CRP levels and statin treatment. Heart. 97 (20), p. e7. [Online].